- Home
- COO
as 07-26-2024 4:00pm EST
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.
| Founded: | 1980 | Country: | United States |
| Employees: | N/A | City: | SAN RAMON |
| Market Cap: | 17.1B | IPO Year: | N/A |
| Target Price: | $111.78 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.70 | EPS Growth: | 16.98 |
| 52 Week Low/High: | $75.94 - $104.07 | Next Earning Date: | 08-28-2024 |
| Revenue: | $3,731,500,000 | Revenue Growth: | 8.87% |
| Revenue Growth (this year): | 9.23% | Revenue Growth (next year): | 6.85% |
Stock Insider Trading Activity of The Cooper Companies Inc. (COO)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| WEISS ROBERT S | COO | Director | Mar 7 '24 | Sell | $102.21 | 153,213 | $15,659,609.63 | 282,772 | SEC Form 4 |
| WEISS ROBERT S | COO | Director | Mar 7 '24 | Sell | $102.18 | 88,075 | $8,999,732.50 | 282,772 | SEC Form 4 |
| PETERSMEYER GARY S | COO | Director | Mar 5 '24 | Sell | $103.51 | 1,000 | $103,506.00 | 5,668 | SEC Form 4 |
| PETERSMEYER GARY S | COO | Director | Jan 4 '24 | Sell | $336.03 | 150 | $50,404.20 | 2,297 | SEC Form 4 |
| WEISS ROBERT S | COO | Director | Dec 19 '23 | Sell | $363.87 | 21,445 | $7,803,192.15 | 128,618 | SEC Form 4 |
| WEISS ROBERT S | COO | Director | Dec 19 '23 | Sell | $364.74 | 27,715 | $10,108,769.10 | 100,903 | SEC Form 4 |
| WEISS ROBERT S | COO | Director | Dec 19 '23 | Sell | $365.51 | 29,272 | $10,699,208.72 | 71,631 | SEC Form 4 |
| WEISS ROBERT S | COO | Director | Dec 19 '23 | Sell | $366.70 | 938 | $343,964.60 | 70,693 | SEC Form 4 |
| PETERSMEYER GARY S | COO | Director | Dec 14 '23 | Sell | $368.55 | 300 | $110,565.00 | 2,464 | SEC Form 4 |
Latest The Cooper Companies Inc. News
COO Breaking Stock News: Dive into COO Ticker-Specific Updates for Smart Investing
Zacks
3 days ago
Reasons to Add The Cooper Companies (COO) to Your Portfolio Now
Argus Research
3 days ago
COO: What does Argus have to say about COO?
Argus Research
10 days ago
COO: Raising target price to $95.00
MT Newswires
11 days ago
Jefferies Upgrades Cooper Companies to Buy From Hold, Adjusts Price Target to $115 From $107
PR Newswire
12 days ago
CooperVision Champions Children's Eye Health at WCPOS V 2024
Argus Research
17 days ago
COO: Lowering target price to $90.00
Argus Research
24 days ago
COO: Lowering target price to $91.00
Simply Wall St.
a month ago
Is The Cooper Companies, Inc.'s (NASDAQ:COO) Recent Price Movement Underpinned By Its Weak Fundamentals?
Compare COO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "COO The Cooper Companies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.